Capstone Investment Advisors
FDMT icon

Capstone Investment Advisors’s 4D Molecular Therapeutics FDMT Stock Holding History

Capstone Investment Advisors’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,917
Closed -$199K – 1786
2025
Q3 		$199K Buy
+22,917
New +$137K ﹤0.01% 1840
2024
Q3 		– Sell
-9,548
Closed -$200K – 2010
2024
Q2 		$200K Buy
+9,548
New +$240K ﹤0.01% 1768
2021
Q2 		– Sell
-5,879
Closed -$255K – 1848
2021
Q1 		$255K Buy
+5,879
New +$260K 0.01% 1382

Other funds holding FDMT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return